Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

Trials to Overcome Drug Resistance to EGFR and ALK Targeted Therapies - Past, Present, and Future.

Spaans JN, Goss GD.

Front Oncol. 2014 Aug 27;4:233. doi: 10.3389/fonc.2014.00233. eCollection 2014. Review.

PMID:
25221748
[PubMed]
Free PMC Article
2.

Maintenance therapies for non-small cell lung cancer.

Blais N, Kassouf E.

Front Oncol. 2014 Aug 19;4:213. doi: 10.3389/fonc.2014.00213. eCollection 2014. Review.

PMID:
25191641
[PubMed]
Free PMC Article
3.

The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging.

Yousefi-Koma A, Panah-Moghaddam M, Kalff V.

Tanaffos. 2013;12(1):16-25. Review. No abstract available.

PMID:
25191445
[PubMed]
Free PMC Article
4.

Adjuvant chemotherapy of non-small cell lung cancer.

Pirker R.

Tanaffos. 2012;11(1):12-7. Review.

PMID:
25191395
[PubMed]
Free PMC Article
5.

Chemotherapy in Metastatic NSCLC - New Regimens (Pemetrexed, Nab-Paclitaxel).

Blais N, Hirsh V.

Front Oncol. 2014 Jul 21;4:177. doi: 10.3389/fonc.2014.00177. eCollection 2014. Review.

PMID:
25101242
[PubMed]
Free PMC Article
6.

Case Report About Fatal or Near-Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test.

Dupont B, Mariotte D, Moldovan C, Grellard JM, Vergnaud MC, Laroche D, Gervais R.

Clin Med Insights Oncol. 2014 Jul 6;8:91-4. doi: 10.4137/CMO.S13897. eCollection 2014.

PMID:
25089092
[PubMed]
Free PMC Article
8.

Treatment paradigms for patients with metastatic non-small cell lung cancer, squamous lung cancer: first, second, and third-line.

Al-Farsi A, Ellis PM.

Front Oncol. 2014 Jun 27;4:157. doi: 10.3389/fonc.2014.00157. eCollection 2014. Review.

PMID:
25019058
[PubMed]
Free PMC Article
9.

Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?

Sgambato A, Casaluce F, Maione P, Rossi A, Ciardiello F, Gridelli C.

J Thorac Dis. 2014 Jun;6(6):578-80. doi: 10.3978/j.issn.2072-1439.2014.06.14. No abstract available.

PMID:
24976974
[PubMed]
Free PMC Article
10.

Nimotuzumab plus chemotherapy versus chemotherapy alone in advanced non-small-cell lung cancer: a multicenter, randomized, open-label Phase II study.

Babu KG, Prabhash K, Vaid AK, Sirohi B, Diwakar RB, Rao R, Kar M, Malhotra H, Nag S, Goswami C, Raina V, Mohan R.

Onco Targets Ther. 2014 Jun 13;7:1051-60. doi: 10.2147/OTT.S63168. eCollection 2014.

PMID:
24966687
[PubMed]
Free PMC Article
11.

Maintaining clarity: Review of maintenance therapy in non-small cell lung cancer.

Dearing KR, Sangal A, Weiss GJ.

World J Clin Oncol. 2014 May 10;5(2):103-13. doi: 10.5306/wjco.v5.i2.103. Review.

PMID:
24829857
[PubMed]
Free PMC Article
12.

Frequent mutations in EGFR, KRAS and TP53 genes in human lung cancer tumors detected by ion torrent DNA sequencing.

Cai X, Sheng J, Tang C, Nandakumar V, Ye H, Ji H, Tang H, Qin Y, Guan H, Lou F, Zhang D, Sun H, Dong H, Zhang G, Liu Z, Dong Z, Guo B, Yan H, Yan C, Wang L, Su Z, Li Y, Jones L, Huang XF, Chen SY, Wu T, Lin H.

PLoS One. 2014 Apr 23;9(4):e95228. doi: 10.1371/journal.pone.0095228. eCollection 2014.

PMID:
24760004
[PubMed - in process]
Free PMC Article
13.

Combining targeted agents and hypo- and hyper-fractionated radiotherapy in NSCLC.

McDonald F, Popat S.

J Thorac Dis. 2014 Apr;6(4):356-68. doi: 10.3978/j.issn.2072-1439.2013.12.05. Review.

PMID:
24688780
[PubMed]
Free PMC Article
14.

Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients.

Li W, Zhou F, Zhou C.

Onco Targets Ther. 2014 Feb 13;7:253-61. doi: 10.2147/OTT.S45096. eCollection 2014. Review.

PMID:
24611018
[PubMed]
Free PMC Article
15.

Targeted therapies in development for non-small cell lung cancer.

Reungwetwattana T, Dy GK.

J Carcinog. 2013 Dec 31;12:22. doi: 10.4103/1477-3163.123972. eCollection 2013. Review.

PMID:
24574860
[PubMed]
Free PMC Article
16.

Update on the evidence regarding maintenance therapy.

Lee JE, Chung CU.

Tuberc Respir Dis (Seoul). 2014 Jan;76(1):1-7. doi: 10.4046/trd.2014.76.1.1. Epub 2014 Jan 29. Review.

PMID:
24523811
[PubMed]
Free PMC Article
17.

Non-small-cell lung cancer: treatment of late stage disease: chemotherapeutics and new frontiers.

Scheff RJ, Schneider BJ.

Semin Intervent Radiol. 2013 Jun;30(2):191-8. doi: 10.1055/s-0033-1342961. Review.

PMID:
24436536
[PubMed]
Free PMC Article
18.

Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.

Maitland ML, Levine MR, Lacouture ME, Wroblewski KE, Chung CH, Gordon IO, Szeto L, Ratko G, Soltani K, Kozloff MF, Hoffman PC, Salgia R, Carbone DP, Karrison TG, Vokes EE.

BMC Cancer. 2014 Jan 4;14:5. doi: 10.1186/1471-2407-14-5.

PMID:
24386952
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Maintenance treatment after induction therapy in non-small cell lung cancer: latest evidence and clinical implications.

Gentzler RD, Patel JD.

Ther Adv Med Oncol. 2014 Jan;6(1):4-15. doi: 10.1177/1758834013510589. Review.

PMID:
24381656
[PubMed]
Free PMC Article
20.

Incidence and risk of treatment-related mortality with anti-epidermal growth factor receptor monoclonal antibody in cancer patients: a meta-analysis of 21 randomized controlled trials.

Li X, Shan BE, Wang J, Xing LP, Guo XJ, Zhang YH, Shi PH, Wang ZY.

PLoS One. 2013 Nov 28;8(11):e81897. doi: 10.1371/journal.pone.0081897. eCollection 2013.

PMID:
24312376
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk